Literature DB >> 6159344

Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.

P J Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6159344     DOI： 10.1093/jac/6.4.535

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

2.  Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.

Authors:  L Aguilar; I P Balcabao; P Salvá; M Martín; J Costa; J Prieto; R Dal-ré
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

3.  Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.

Authors:  R T Chow; T J Dougherty; H S Fraimow; E Y Bellin; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.

Authors:  D M Benbrook; R V Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

5.  Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.

Authors:  L J Piddock; R N Walters; J M Diver
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

6.  Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones.

Authors:  J S Wolfson; D C Hooper; D J Shih; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 7.  Lomefloxacin clinical pharmacokinetics.

Authors:  C D Freeman; D P Nicolau; P P Belliveau; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

8.  Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.

Authors:  J S Wolfson; D C Hooper; G L McHugh; M A Bozza; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.